Free Trial

Canopy Growth (TSE:WEED) Price Target Cut to C$1.60 by Analysts at ATB Capital

Canopy Growth logo with Medical background

Canopy Growth (TSE:WEED - Free Report) had its price target reduced by ATB Capital from C$3.20 to C$1.60 in a research report released on Tuesday,BayStreet.CA reports. They currently have an underperform rating on the stock.

Separately, Canaccord Genuity Group cut their price objective on Canopy Growth from C$2.50 to C$1.50 and set a "sell" rating for the company in a research report on Monday, February 10th.

View Our Latest Research Report on WEED

Canopy Growth Stock Performance

Shares of WEED stock traded up C$0.09 during trading hours on Tuesday, reaching C$1.86. 2,220,360 shares of the company's stock were exchanged, compared to its average volume of 1,733,006. The company has a debt-to-equity ratio of 120.38, a current ratio of 1.39 and a quick ratio of 2.32. The company's 50 day moving average is C$1.80 and its two-hundred day moving average is C$2.80. The company has a market cap of C$299.21 million, a P/E ratio of -0.27, a price-to-earnings-growth ratio of -0.01 and a beta of 1.79. Canopy Growth has a 1 year low of C$1.09 and a 1 year high of C$11.89.

About Canopy Growth

(Get Free Report)

Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.

Read More

Should You Invest $1,000 in Canopy Growth Right Now?

Before you consider Canopy Growth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.

While Canopy Growth currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Dirt-Cheap Stocks in a Market That’s Getting Expensive
Top 3 Defense Stocks to Profit From $175 Billion Golden Dome
Top 5 Stocks for June: AI Picks That Aren’t NVIDIA

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines